Antigen-directed p53 restoration in <i>TP53</i>-mutated myeloid neoplasms: a hypothesis and theory perspective. [PDF]
Medawar G, Pyle S, Baratam P, Coltoff A.
europepmc +1 more source
Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery. [PDF]
Yanagida K +9 more
europepmc +1 more source
Co-mutation landscape and prognostic impact of genomic complexity in EGFR-mutant non-small cell lung cancer. [PDF]
Yang X +6 more
europepmc +1 more source
Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms. [PDF]
Senapati J +19 more
europepmc +1 more source
Li-Fraumeni Syndrome: Current Perspectives on Molecular Pathogenesis, Surveillance Strategies, Clinical Management and Pediatric Considerations. [PDF]
Graifman G +4 more
europepmc +1 more source
Synthetic lethality in TP53-mutant acute myeloid leukemia. [PDF]
Patel SA.
europepmc +1 more source
Comparative analysis of TP53 gene in Tupaia belangeri subspecies (Tupaia belangeri yaoshanensis vs. Tupaia belangeri chinensis) and identification of mutations in spontaneous tumor cases. [PDF]
Cao Y, Tang H, Liang L, Leng J, Huang W.
europepmc +1 more source
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis. [PDF]
Leo J +14 more
europepmc +1 more source
Coagulation activation is associated with genomic-instability-related features in TP53-mutated AML and MDS: routine laboratory patterns beyond classical disseminated intravascular coagulation. [PDF]
Xin X, Zheng C, Huang J, Xie Q.
europepmc +1 more source

